XML 32 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Apr. 26, 2013
Apr. 27, 2012
OPERATING ACTIVITIES:    
Net income (loss) $ 131,937 $ 132,322
Adjustments to reconcile net income (loss) to net cash (used in)/provided by operating activities:    
Depreciation 38,907 42,917
Amortization 3,270 3,306
Stock-based compensation 9,173 5,710
(Gain)/loss on asset divestitures (1,602) 496
Changes in certain assets and liabilities, net of effects of acquired businesses:    
(Increase)/decrease in accounts and notes receivable (31,227) (67,109)
(Increase)/decrease in inventories and other assets (86,744) (63,790)
Increase/(decrease) in trade accounts payable and other accrued liabilities (56,189) (32,861)
Increase/(decrease) in income taxes payable 8,277 831
Increase/(decrease) in other deferred liabilities 7,051 9,815
Settlement of treasury lock contracts 0 (27,875)
Other (3,175) (1,875)
Net Cash (Used In)/Provided By Operating Activities 19,678 1,887
INVESTING ACTIVITIES:    
Purchases of property, plant and equipment (30,105) (30,085)
Acquisition of businesses, net of cash acquired (34,811) 0
Cash proceeds on disposal of assets 6,211 2,987
(Increase)/decrease in restricted cash (516) (931)
Net Cash (Used In)/Provided By Investing Activities (59,221) (28,029)
FINANCING ACTIVITIES:    
Net proceeds from issuance of debt 0 396,816
Net change in other borrowings (5,752) (36,376)
Net proceeds (repayments) of commercial paper 226,948 (153,955)
Proceeds from sale of treasury stock 15,008 26,180
Treasury stock purchases (190,215) (145,322)
Excess tax benefit from stock-based compensation 11,703 7,605
Dividends paid (41,120) (37,075)
Purchase of equity award shares 0 (7,614)
Net Cash (Used In)/Provided By Financing Activities 16,572 50,259
Increase/(Decrease) in Cash and Cash Equivalents (22,971) 24,117
Effect of exchange rate changes on Cash and Cash Equivalents (2,047) 6,207
Cash and Cash Equivalents at Beginning of Period 253,327 178,167
Cash and Cash Equivalents at End of Period $ 228,309 $ 208,491